NAPLES, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) — Intetics, a leading American technology company, released a White Paper covering the eight biggest fears keeping businesses from enhancing processes with custom software.
Imagine you have something in your business that relies on outdated software or even manual processes to do repetitive tasks or other day-to-day operations.
A popular approach in IT says: “If it ain’t broke, don’t fix it,” or better don’t “make a revolution” with new custom software, as it carries a risk of wasting precious time and effort with unclear results.
New software sometimes causes more problems than it solves; there are compatibility issues, the general chaos of rolling it out, and making sure everything works.
There are tons of other myths about custom software development:
- Myth 1: Custom Software Requires Heavy Initial Investment & Lengthy Talent Searches
- Myth 2: The Project Predictability Problem
- Myth 3: Ready-Made Products Are Always Easier and Cheaper
- Myth 4: It’s Impossible to Create a Good Product with Incomplete Specifications
- Myth 5: Outstaffing Team Can Take Over In-House Developers Jobs and Gain Project Ownership
- Myth 6: Lack of Control over Remote Development Teams
- Myth 7: It’s Enough to Hire a Freelance Developer for the IT Project’s Success
- Myth 8: Maintenance Is Overwhelming
The truth is that, if developed and implemented smartly with your goals in mind, it can be a powerful way to automate processes, reduce costs, and generate more revenue.
The White Paper covers these eight biggest fears around custom development and what measures & methodologies smash them up. Download the full version.
About Intetics
Intetics Inc. is a leading American technology company providing custom software application development, distributed professional teams creation, software product quality assessment, and “all-things-digital” solutions built with SMAC, RPA, AI/ML, IoT, blockchain, and GIS/UAV/LBS technologies.
Based on proprietary pioneering business models of Offshore Dedicated Team® and Remote In-Sourcing®, an advanced Technical Debt Reduction Platform (TETRA™) and measurable SLAs for software engineering, Intetics helps innovative organizations capitalize on global talent with our in-depth engineering expertise based on our Predictive Software Engineering framework.
Intetics core strength lays in design of software products in conditions of incomplete specifications. We have extensive industry expertise in Education, Healthcare, Logistics, Life Sciences, Finance, Insurance, Communications, and custom ERP, CRM, Intelligent Automation and Geospatial solutions.
Our advanced software engineering background and outstanding quality management platform, along with an unparalleled methodology for talent acquisition, team building and talent retention, guarantee that our clients receive exceptional results for their projects. At Intetics, our outcomes do not just meet clients’ expectations, they have been exceeding them for a quarter of a century. Intetics operates from multiple offices in the USA, Europe and Latin America, hiring the best talent available worldwide.
Intetics is ISO 9001 (quality) and ISO 27001 (security) certified and a Microsoft Gold, Amazon, and UiPath Silver partner. The company’s innovation and growth achievements are reflected in winning prestigious titles and awards, including Inc5000, Software 500, CRN 100, American Business, Deloitte Fast 50, European IT Excellence, Best European BPO, Stevie People’s Choice, Clutch and ACQ5 Awards, IAOP Global Outsourcing 100 and Fortune Innovative 300 lists.
You can find more information at https://intetics.com
CONTACT: Irina Dubovik, Digital Marketing Director Intetics, i.dubovik@intetics.com +1 (239) 217-4907
- Investigational combination of first-in-class bispecific antibodies TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease - June 15, 2025
- [Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients - June 15, 2025
- HostColor Expands Its AMD Dedicated Server Offerings in LA and New York - June 14, 2025
